New york stem cell foundation, the:1210698 [23-004533]

Ended Purchase Order Awarded Last action

Contract number
75N95023P00522
Awardee
Awarding agency
Obligated
$105,000

Award facts

Contract value 100% obligated
$105,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
New York, NY 10019, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $105,000 firm fixed price purchase order to New York Stem Cell Foundation Inc. as the prime contractor. The contract is to support the agency's research efforts and will be performed in New York, New York over a one year period from September 2023 through September 2024. No major subcontractors or set aside designations were indicated. The National Institute on Drug Abuse conducts and supports research on the health aspects of drug abuse and addiction, which this contract appears intended to advance through the Foundation's work in stem cell research.

Quick answers

Who was awarded contract 75N95023P00522?

75N95023P00522 was awarded to New York Stem Cell Foundation Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 15, 2023.

How much is contract 75N95023P00522 worth?

The government has obligated $105,000 on 75N95023P00522.

Was contract 75N95023P00522 competed?

The extent of competition for 75N95023P00522 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award